期刊文献+

血必净注射液对急性脑梗塞患者非感染性炎症的治疗研究 被引量:1

Clinical research on treating infective inflammation in ACI patients with the Xuebijing injection
下载PDF
导出
摘要 目的:研究血必净注射液对急性脑梗塞患者非感染性炎症反应的治疗作用。方法:将无感染性并发症的急性脑梗塞患者分成治疗组和对照组。对照组采用常规治疗,治疗组在此基础上加用血必净注射液,比较治疗后C反应蛋白水平有无显著性差异。结果:治疗组的C反应蛋白水平明显低于对照组。结论:血必净注射液能够改善急性脑梗塞患者非感染性炎症反应。 Objective: To study efficacy of the Xuebijing injection on infective inflammation in ACI patients. Methods: Patients were divided into two groups. The control group received conventional treatment; the other group received the Xuebijing injection more. The levels of CRP in two groups were compared. Results: The CRP in the treatment group was better. Conclusion: The Xuebijing injection can improve infective inflammation in ACI patients.
出处 《中医临床研究》 2016年第2期21-22,共2页 Clinical Journal Of Chinese Medicine
关键词 血必净 脑梗塞 C反应蛋白 The Xuebijing injection Cerebral infarction CRP
  • 相关文献

参考文献9

二级参考文献41

  • 1姚辉,林汉华,于芳,黄晓燕,夏治.肥胖大鼠血清C反应蛋白水平的动态变化及罗格列酮干预的影响[J].临床内科杂志,2004,21(8):561-563. 被引量:2
  • 2陈可冀,李连达,翁维良.血瘀证与活血化瘀研究[J].中西医结合心脑血管病杂志,2005,3(1):1-2. 被引量:241
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33029
  • 4Senn J J, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 ( SOCS-3 ), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes [ J ]. J Biol Chem, 2003,278 (16) :13740-13746.
  • 5Krogh-Madsen R, Plomgaard P, Keller P, et al. Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue [ J ]. Am J Physiol Endocrinol Metab, 2004,286(2) :234-238.
  • 6Ruan H, Hacohen N, Golub TR, et al. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activa- tion by TNF-alpha is obligatory [ J ]. Diabetes, 2002,1 (5) :1319- 1336.
  • 7Lagathu C, Bastard JP, Auclair M, et al. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by msiglitazone [ J ]. Bioehem Biophys Res Cormnun, 2003,311(2) :372-379.
  • 8Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [J]. Chest, 1992,101 : 1028.
  • 9Koch T. Origin and mediators involved in sepsis and the systemic inflammatory response syndrome[J]. Kidney Int,1998,53(64):66.
  • 10Chang LT, Yuen CM, Lion CW, et al, Link between interleukin-10 level and outcome after ischemic stroke[J].Neuroim munomodulation, 2010,17(4): 223-228.

共引文献338

同被引文献20

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部